Veeral Sheth to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Veeral Sheth has written about Neoplasm Recurrence, Local.
Connection Strength
0.033
-
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2022 07; 239:180-189.
Score: 0.033